Safer treatment doses for low molecular weight heparins: summary of a safety report from the National Patient Safety Agency.
National Reporting and Learning Service, National Patient Safety Agency, London W1T 5HD, UK. tara.lamont@npsa.nhs.uk
Tara
T
Lamont
David
D
Cousins
Catherine
C
Rosario
D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008508:Medication Errors / Q000517:prevention & control; D017751:Safety Management
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight